Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Charlene R Taylor"'
Autor:
Gene D. Morse, Charlene R Taylor, Richard W. Browne, Robin DiFrancesco, Yan Wang, Susan L. Rosenkranz
Publikováno v:
Ther Drug Monit
BACKGROUND: The Clinical Pharmacology Quality Assurance (CPQA) program provides semi-annual proficiency testing of antiretroviral analytes for eleven U.S. and international clinical pharmacology laboratories to ensure inter-laboratory comparability.
Autor:
Robin DiFrancesco, Susan L. Rosenkranz, Suzanne M. Siminski, Charlene R Taylor, Gene D. Morse, Richard W. Jenny, Poonam Pande
Publikováno v:
Therapeutic Drug Monitoring. 35:631-642
Among National Institutes of Health HIV Research Networks conducting multicenter trials, samples from protocols that span several years are analyzed at multiple clinical pharmacology laboratories (CPLs) for multiple antiretrovirals. Drug assay data a
Autor:
Robin DiFrancesco, Poonam Pande, Charlene R Taylor, Gene D. Morse, Susan Siminski, Kelly M. Tooley, Susan L. Rosenkranz
Publikováno v:
Clinical Pharmacology & Therapeutics. 93:479-482
The global HIV epidemic continues to grow in certain regions while contracting in others, necessitating a broadened research agenda, including clinical pharmacology of tuberculosis, hepatitis, malaria, and immune activation/inflammation, underscoring
Autor:
Gene D. Morse, Kelly M. Tooley, Poonam Pande, Charlene R Taylor, Richard W. Jenny, Susan L. Rosenkranz, Robin DiFrancesco, Suzanne M. Siminski
Publikováno v:
Bioanalysis. 6(20)
Background: Clinical trial specimens tested for antiretroviral (ARV) concentrations often require compliance with Clinical Laboratory Improvement Act and/or the Food and Drug Administration bioanalytical guidance. Experimental: The Clinical Pharmacol
Publikováno v:
Bioanalysis. 5(3)
Research in the many areas of HIV treatment, eradication and prevention has necessitated measurement of antiretroviral (ARV) concentrations in nontraditional specimen types. To determine the knowledgebase of critical details for accurate bioanalysis,
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:394-397
The disposition of zidovudine (ZDV) was examined during chronic oral dosing (300 mg every 4 h while awake) for 12 weeks in eight asymptomatic patients with hemophilia who were infected with the human immunodeficiency virus. Pharmacokinetic studies we
Publikováno v:
Journal of the American Geriatrics Society. 41:808-810
Objective: To examine the disposition of intramuscular (IM) cefonicid in elderly patients with bacterial pneumonia. Design: Pharmacokinetic study. Setting: A 620-bed university-affiliated long-term care institution with its own 39-bed acute care unit